Allchem Lifescience files for ₹190 crore IPO in Gujarat

Allchem Lifescience has filed for a ₹190 crore initial public offering (IPO) with the Securities and Exchange Board of India (SEBI). The IPO includes a fresh issue of equity shares and an offer for sale of 71.55 lakh shares by promoters. The company plans to use ₹130 crore from the fresh issue to repay debt, with the rest for general corporate purposes. Allchem Lifescience, based in Gujarat, specializes in active pharmaceutical ingredients and has been growing its revenue steadily. Established in 2017, Allchem Lifescience manufactures 263 products, including key raw materials for pharmaceuticals. The company reported a revenue of ₹7.84 crore for the six months ending September 2024, with a profit after tax of ₹1.09 crore.